I'm looking
for help...
Aidpage is free!
   

Free downloads: GrantGate®  Federal Money Retriever®

DRUG ABUSE ASPECTS OF HIV/AIDS AND OTHER INFECTIONS

Published on AidPage by IDILOGIC on Jun 24, 2005
Administered by:

Department of Health and Human Services, National Institutes of Health, National Institutes of Health
(see all US Federal Agencies)

Explore all postings for this grant program:
  • Original Grant - Oct 22, 2003
Applications Due:


Multiple Receipt Dates - See Link to Full Announcement for details.

total funding: Not Available
max award: none
min award: none
cost sharing, matching: No
number of awards: Not Available
type of funding: Grant
Description:

The National Institute on Drug Abuse (NIDA) supports research on the natural
history, epidemiology, etiology, virology and pathogenesis, prevention, and
treatment of drug abuse and drug abuse aspects of HIV/AIDS and other
infectious agents [e.g., hepatitis B virus (HBV), hepatitis C virus (HCV),
other sexually transmitted infections (STIs), and tuberculosis (TB)]. AIDS was
first recognized as a growing epidemic among men who have sex with men (MSM)
and injection drug users (IDUs) and their sexual partners in the early 1980s.
While considerable scientific progress has been made since then in
understanding, preventing, and treating the intertwined epidemics of drug
abuse and HIV/AIDS, much remains unknown or poorly understood today. Emerging
drugs of abuse, such as the club drugs ecstasy (MDMA), GHB, ketamine, and
methamphetamine, as well as more potent supplies of heroin, cocaine, and
marijuana, are continually changing the profiles of populations at risk.
Moreover, these drugs often contain adulterants, and are used in risky social
contexts in combination with alcohol and other drugs, including Viagra,
poppers, and tobacco.

In the United States today, over 77,000 women have been diagnosed with AIDS
attributed to injection drug use or sex with an IDU, and nearly a third of
AIDS cases in adult/adolescent women diagnosed in 2001 reported injection drug
use or sex with an IDU as their primary risks. Racial and ethnic minority
populations of both genders have been deeply affected by drug abuse, HIV/AIDS,
and other infectious diseases in recent years, with new HIV infections
continuing at an alarming rate in the U.S. and in other nations. There are an
estimated 800,000 to 900,000 people living with HIV in the U.S., with
approximately 40,000 new HIV infections occurring every year. By race, more
than half of new HIV infections in 2001 and deaths attributable to AIDS in
2000 occurred among African Americans, although they represent only 13% of the
U.S. population.

This PA seeks to stimulate a range of investigator-initiated studies to
advance the scientific knowledge base on drug abuse aspects of HIV/AIDS and
other serious infections. Researchers are invited to address diverse and
cross-cutting issues in multiple disciplines, including, among others:
virology, bacteriology, molecular epidemiology, etiology, therapeutics and
vaccines, ethnography and behavioral epidemiology, mathematical modeling and
simulations, and the behavioral and social sciences.

Who can apply:

Anyone/General Public
City Or Township Governments
County Governments
Federally Recognized Indian Tribal Governments
Independent School Districts
Individual/Family
Minority Group
Native American Organization
Non-Government - General
Nonprofits Having A 501(C)(3) Status With The IRS, Other Than Institutions Of Higher Education
Nonprofits That Do Not Have A 501(C)(3) Status With The IRS, Other Than Institutions Of Higher Education
Other Private Institution/Organization
Private Institutions Of Higher Education
Private Nonprofit Institution/Organization (Includes Institutions Of Higher Education, Hospitals)
Profit Organization
Public And State Controlled Institutions Of Higher Education
Public Housing Authorities/Indian Housing Authorities
Small Business (Less Than 500 Employees
Special District Governments
State (Includes District Of Columbia; Includes Institutions Of Higher Education And Hospitals)
U.S. Territories And Possessions (Includes Institutions Of Higher Education, Hospitals)

Eligible functional categories:
Funding Sources:

Drug Abuse Research Programs

More Information:

http://grants.nih.gov/grants/guide/pa-files/PA-04-007.html

If you have problems accessing the full announcement, please contact: NIH OER Webmaster

Address Info:

Office of Extramural Programs
6705 Rockledge Drive
Bethesda, MD 20892-7963

SPONSORED LINKS
Free downloads: GrantGate®  Federal Money Retriever®
Apply for grants and loans! Click here to start